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Objectives. The development of effective strategies to prevent childhood obesity and its 
comorbidities requires new, reliable early biomarkers. Here, we aimed to identify in peripheral 
blood cells (PBCs) potential transcript-based biomarkers of unhealthy metabolic profile 
associated to overweight/obesity in children. 
Methods. We performed a whole-genome microarray analysis in blood cells to identify genes 
differentially expressed between overweight and normal weight children to obtain novel 
transcript-based biomarkers predictive of metabolic complications. 
Results. The most significant enriched pathway of differentially expressed genes was related to 
oxidative phosphorylation, for which most of genes were down-regulated in overweight versus 
normal weight children. Other genes were involved in carbohydrate metabolism/glucose 
homeostasis or in lipid metabolism (e.g. TCF7L2, ADRB3, LIPE, GIPR), revealing plausible 
mechanisms according to existing biological knowledge. A set of differentially expressed genes 
was identified to discriminate in overweight children those with high or low triglyceride levels.  
Conclusion. Functional microarray analysis has revealed a set of potential blood-cell transcript-
based biomarkers that may be a useful approach for early identification of children with higher 
predisposition to obesity-related metabolic alterations.  
  




Obesity is nowadays considered one of the main public health problems, affecting not only 
adults but also children. WHO estimated that 42 million children under the age of 5 were 
overweight or obese in 2013 (1). What is even more worrying is the greater probability of an 
obese child to maintain obesity into adulthood. Moreover, early onset of obesity is associated 
with an increased incidence of co-morbidities, such as type 2 diabetes, non-alcoholic fatty liver 
disease, cardiovascular diseases and metabolic syndrome (2, 3). Knowing that obesity is 
influenced by several genetic, environmental and behavioural factors, and that the success of 
treatment is limited, prevention of obesity at early ages becomes a major need and should be 
one of the main focuses of attention. Thus, early diagnosis seems important for management 
and prevention of childhood obesity. The identification of biomarkers of predisposition to 
obesity-associated metabolic alterations could aid present/current strategies in decreasing in a 
more effective manner obesity associated co-morbidities, by targeting the underlying processes. 
Transcriptome analysis in peripheral blood cells (PBCs), considering whole peripheral blood or 
a subpopulation of white blood cells, the so-called peripheral blood mononuclear cells 
(PBMCs), has been proposed as a research strategy to identify new biomarkers and candidate-
genes for a number of diseases based on differentially expressed mRNA profiles (4-7). PBCs 
have the advantage of being easy to collect, unlike invasive biopsies. Moreover, gene expression 
in these cells may reflect the responses of internal organs, such as adipose tissue and liver, and 
thereby have been proposed as a source of biomarkers of health and disease (8-10). More 
specifically, PBCs have been proposed as an appropriate method for studying the cardiovascular 
system (6), or as a source of transcript-based biomarkers for very early stages of acute coronary 
disease (5). In addition, the suitability of blood cells as a potential source for biomarkers of 
metabolic adaptations to food intake and body weight maintenance has been reported both in 
animal (8, 9, 11) and human studies (12, 13). Besides, in murine models, expression levels of 
selected genes in PBCs have been proposed as predictive biomarkers of a healthy or distorted 
metabolic state due to interventions during the perinatal period (14, 15).  
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In the present study, a whole genome microarray analysis was performed in PBCs to identify 
genes differentially expressed between overweight and normal weight children, using a cross-
sectional design, in order to derive novel transcript-based biomarkers that could be predictive of 
metabolic complications in early life. These biomarkers could be helpful for identifying 
particularly those obese children who are at risk of metabolic complications, hence allowing 
early interventions in a more effective way.  
Materials and Methods 
Participants 
IDEFICS is a large European multi-centre study on childhood obesity (details in (16)). Using a 
cross-sectional design, whole-genome microarray analysis has been performed in PBCs from a 
subgroup of 32 individuals with normal weight (17) and overweight (15), belonging to the 
Spanish IDEFICS cohort. Children included in the analysis were randomly selected within 
normal weight and overweight individuals and matched by sex. BMI categories were defined 
according to Cole (17). The age range was 4.7-8.0 years.  
Blood sampling and processing for gene expression analysis 
For each participant, a total of 2.5 mL peripheral blood was collected under fasting conditions 
into PAXgene vacutainer tubes (Qiagen, Izasa-Barcelona, Spain) via antecubital fossa 
venipuncture. Total RNA was isolated using the PAXgene blood RNA kit according to the 
manufacturer’s instructions (Qiagen) and as previously described (13). 
Microarray processing  
From each sample, 80 ng of RNA was reverse transcribed to complementary DNA (cDNA) 
using the Agilent Low Input Quick Amp Labeling kit (Agilent Technologies, Inc., CA, USA) 
according to the manufacturer’s protocol. Then, half of the cDNA sample (10 µl) was used for 
the linear amplification of RNA and labelling with cyanine-3 (Cy3) or Cy5. Transcription and 
labelling were carried out at 40 °C for 2 h. The labelled and amplified cRNA samples were 
purified using Qiagen Rneasy MiniSpin columns (Qiagen, Madrid, Spain). The incorporation of 
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dyes and cRNA concentration was measured using the NanoDrop ND 1000 spectrophotometer 
(NanoDrop Techonologies, Ins., Wilmington, DE). Then, 825 ng of cRNA labelled with Cy5 
from each sample and 825 ng of Cy3 pool was hybridized on 4x44K G4845A human whole 
genome Agilent microarrays (Agilent Technologies, Inc., Santa Clara, CA, USA) for 17 h at 65 
°C in hybridization chambers in an oven rotating at 10 rpm (Agilent Technologies). After 
hybridization, the arrays were washed with "GE wash buffer 2" for 1 min at 37 °C, followed by 
acetonitrile for 10 s at room temperature, and finally with a solution for stabilization and drying 
for 30 s at room temperature, according to the manufacturer’s protocol (Agilent Technologies). 
Microarray data analysis 
The arrays were scanned with an Agilent Microarray Scanner (Agilent Technologies). Scanned 
images were examined for visible defects and proper grid alignment. The intensities of the 
signals from each spot were quantified, and the raw data were extracted using Feature 
Extraction Software version 10.10.1.1 (Agilent Technologies).  
Background correction was performed by subtracting the background intensities from the 
foreground intensities. Normalisation within and between arrays was conducted using the loess 
method and the quantile method, respectively. All samples showed correct normalisation and 
were thus used in further statistical analysis.  
The Babelomics 4.3 platform (http://babelomics.bioinfo.cipf.es), a suite of web tools for 
microarray data analysis (18), was applied for statistical analysis. The patterns of probes 
matching for the same gene were merged, and hence obtaining the median. Next, differential 
gene expression between overweight and normal weight children was assessed by the Limma 
test. Fold changes were the difference in log2 mean values between experimental groups. The 
threshold of significance for this statistical test was set at p<0.01. To control for false positives 
we selected gene expression differences for a false discovery rate (FDR) (19) of 16%. 
Biological information of the identified genes was obtained in available databases (NCBI, 
UniProt, Genecards). In addition, to gain insight into biological mechanisms, pathway analysis 
was conducted using MetacoreTM (GeneGo Inc). Genes with expression levels significantly 
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different between normal weight and overweight children were plotted in a heat map using R (v 
3.1.1, R Development Core Team). Partial least squares discriminant analysis (PLS-DA) was 
performed using the Excel add-in Multibase (Numerical Dynamics, Japan) to select a more 
reduced number of gene transcripts to discriminate between overweight and normal weight 
subjects, with high and low metabolic risk.  
Reverse transcription quantitative polymerase chain reaction (RT-qPCR) analysis 
To validate the results from the microarray analysis, mRNA expression levels of 10 selected 
genes were measured by RT-qPCR. These genes included the five genes from oxidative 
phosphorylation chain that displayed the greatest changes in the array analysis and other 
selected genes related to food intake control, signalling and carbohydrate metabolism (see 
Supplemental Table 1 for further details). RT-qPCR was performed as previously described 
(13). Briefly, 0.25 µg of total RNA was denatured at 65 °C for 10 min and then reverse 
transcribed to cDNA using MuLV reverse transcriptase at 20ºC for 15 min, 42 °C for 30 min, 
with a final step of 5 min at 95 °C in an Applied Biosystems 2720 Thermal Cycler. Each PCR 
was performed from diluted (1/5) cDNA template, forward and reverse primers (1 mM each) 
and Power SYBER Green PCR Master Mix. Real time PCR was performed using the Applied 
Biosystems StepOnePlusTM Real-Time PCR Systems with the following profile: 10 min at 95 
ºC, followed by a total of 40 two- temperature cycles (15 s at 95 ºC and 1 min at 60 ºC). In order 
to verify the purity of the products, a melting curve was produced after each run according to 
the manufacturer's instructions. The threshold cycle (Ct) was calculated using the instrument’s 
software (StepOne Software version 2.2.2), and the relative expression of a target gene to a 
housekeeping gene was calculated. Tripartite motif containing 27 (TRIM27) was chosen as 
housekeeping gene because showed equal expression levels across all groups. 
Statistical analysis  
No blinding was carried out for data analysis. Data are presented as mean and the standard error 
of the mean (SEM). The statistical analysis of microarray data was conducted as described 
above. Statistical analysis of the anthropometric and biochemical parameters was performed 
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using SPSS version 20. The median value of each gene’s expression distribution in the overall 
group was selected as an arbitrary cut-off point to group gene expressions in low and high 
expression categories. Levene´s test was performed to assess whether the variance is equal 
between groups. Single comparisons between groups were assessed by Student’s t-test. Two-
way ANOVA was used to determine differences between BMI and gene expression categories 
(high vs low). Threshold of significance was defined at p<0.05.  
Results 
Subject characteristics 
Characteristics of the subjects included in the study are shown in Table 1. The random sample 
consists of 32 children from the Spanish cohort of the IDEFICS study, uniformly distributed by 
weight and sex, and with a range of age between 4.7 and 8.0 years. Compared with normal 
weight, overweight children exhibited as expected higher body weight, BMI and BMI z-score 
(20), subcutaneous fat (calculated as the sum of four different skin folds), waist/height ratio and 
HOMA-IR index, and also presented higher insulinemia and triglyceridemia (p<0.01, Student’s 
t-test). No differences were found between normal weight and overweight children concerning 
total, HDL and LDL cholesterol levels. Mean age of overweight children was significantly 
higher than that of normal weight children. 
Gene expression profiling in PBCs 
Of the 45,220 probes tested in the microarray analysis, 29,094 probes remained after 
background correction, normalization and merging replicated probes and were used for further 
analysis. In total, 1,716 unique genes were found to be expressed significantly different between 
normal weight and overweight children (p<0.01; Limma test). There were 550 unknown genes, 
50 non coding genes, and 39 were pseudogenes and hence were not considered in the following 
steps. From the remaining 1,077 known coding genes, 505 were down-regulated and 572 up-
regulated in overweight compared to normal weight children. The results from the array 
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concerning the 1,077 genes differently expressed between normal weight and overweight 
children across individual samples are depicted in a heat map (see Figure 1). 
Functional and biological analysis  
Using available databases (NCBI, UniProt and Genecards), the 1,077 known genes with 
significantly different expression levels between normal weight and overweight children were 
classified into several biological processes according to their function (Supplemental Figure 1). 
The biological processes showing the highest number of differentially expressed genes were 
related to transcription/translation machinery (n=223), cell turnover (n=123), signalling 
(n=121), immune system (n=78), metabolism of proteins (n=56), transport (n=53), metabolism 
of lipids (n=50), nervous system (n=45), central metabolism (n=44) and cytoskeleton (n=34). 
Other biological processes with a notable number of differently expressed genes (n=12-30) were 
related to neural signalling, blood, sensory perception of taste and smell, metabolism of 
carbohydrates, redox metabolism, epigenetic modification, metabolism of amino acids and 
protein or lipid glycosylation. The remaining genes were related to the metabolism of 
nucleotides and amines, metabolism of vitamins and minerals, cell communication, food intake 
control and vascular homeostasis (with 11 or less genes involved in each process). Other genes 
related to biological processes such as autophagy, cell-cell adhesion, collagen, keratins, extra 
cellular matrix, etc. were grouped under 'miscellanea'  
The set of 1,077 known genes was further analysed for functional and biological pathways using 
the MetaCoreTM platform (GeneGo Inc). The top ten pathway maps are listed in Table 2. The 
most significant enriched pathway in our data set was related to mitochondrial oxidative 
phosphorylation. Notably, most of the genes involved in this pathway were down-regulated in 
overweight compared to normal weight children. Results regarding the five genes related to 
oxidative phosphorylation displaying the greatest changes in the microarray analysis (ATP5O, 
NDUFS5, NDUFB8, COX6C and ATP1F1) were fully validated by RT-qPCR (Supplemental 
Table 1).  
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Expression levels of genes involved in the tricarboxylic acid (TCA) cycle were also reassessed, 
since this process supplies NADH and succinate to oxidative phosphorylation. Notably, key 
genes in the TCA cycle were generally down-regulated in overweight compared to normal 
weight children, but particularly regarding succinate handling. This is the case of SUCLG2 
(succinate-CoA ligase, GDP-forming, beta subunit), SDHB (succinate dehydrogenase complex, 
subunit B, integral membrane protein, 15kDa), SDHC (succinate dehydrogenase complex, 
subunit C, integral membrane protein, 15kDa) and MDH2 (malate dehydrogenase 2, NAD 
(mitochondrial)). Furthermore, genes encoding for two subunits of the pyruvate dehydrogenase 
(PDH) multi-enzyme complex, PDHB and PDHX, which catalyse the overall conversion of 
pyruvate to acetyl coenzyme and provide the primary link between glycolysis and the TCA 
cycle, were down-regulated in overweight children compared to normal weight children 
(p=0.013 and p=0.017, respectively, Limma test,). Up-regulated mRNA expression was also 
detected in overweight children for PC (pyruvate carboxylase), which catalyses carboxylation of 
pyruvate to form oxaloacetate.  
Besides the above mentioned, other differentially expressed genes between normal weight and 
overweight children are suggested as relevant regarding obesity-related metabolic alterations, 
according to existing biological knowledge. Among them are the transcription factor 7-like 2 
(TCF7L2) and the gastric inhibitory polypeptide receptor (GIPR) (associated with carbohydrate 
metabolism and glucose homeostasis) or the adrenergic, beta-3-, receptor (ADRB3) and the 
lipase, hormone-sensitive (LIPE) (associated with lipid metabolism). 
Biomarker selection  
To refine intergroup differences between normal weight and overweight children and select the 
most relevant and discriminatory genes with the greatest potential as biomarkers, data were also 
analysed with the partial least squares discriminant analysis (PLS-DA). The set of 1,077 genes 
was included in the analysis. PLS-DA score plot also showed a clear separation between normal 
weight and overweight children (Figure 2A). We retained those 30 genes with the highest 
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loading in PC1 and in PC2 (Supplemental Table 2) and carried out a new PLS-DA. We obtained 
a model with a clear separation between normal weight and overweight individuals (Figure 2B). 
PC1 and PC2 accounted for 45.7% and 29.9 % of the variance. The ten variables that mostly 
contributed to the model, all of them included in the PC1, were zinc finger protein 418 
(ZNF418), natriuretic peptide A (NPPA), polymerase (RNA) I polypeptide C, 30kDa 
(POLR1C), adrenergic, beta-3-, receptor (ADRB3), purinergic receptor P2X, ligand-gated ion 
channel, 2 (P2RX2), dynein, axonemal, light chain 4 (DNAL4), neuronal signalling (cortistatin 
(CORT), trefoil factor 1 (TFF1), neuronal growth regulator 1 (NEGR1) and Interleukin 15 
receptor, alpha (IL15RA) (Figure 2C). 
Association studies of gene expression with circulating triglyceride levels  
Children were grouped into categories (low/ high) according to selected biochemical 
parameters, HOMA index, insulin and triglycerides (TG). The median value of each parameter’s 
distribution in the overall group was selected as a cut-off point to define these categories. A new 
PLS-DA was built (including the 1,077 genes differentially expressed between normal weight 
and overweight children) to identify genes that differentiate children according not only to their 
body weight, but also to their metabolic risk. Only the results obtained in PLS-DA for 
discrimination of children with high and low TG levels within normal weight and overweight 
children displayed a valid model (Supplemental Figure 2). The PLS-DA showed that within 
normal weight children the model does not discriminate between those having high or low TG 
levels, because both groups are located in the quadrant with the higher score for PC1 (Figure 3). 
However, this model shows better separation within overweight children (Figure 3). Overweight 
children with low TG levels were mainly located on the right side of PC1, as normal weight 
children. This suggests that those genes with a high loading score in PC1 may be good 
candidates as biomarkers to discriminate between overweight children with high or low TG 
levels. The genes are listed in Supplemental Table 3. It is noteworthy that the list of genes with 
high loadings in PC1 includes 8 of the 10 genes previously listed in Figure 2C (ZNF418, NPPA, 
POLR1C, ADRB3, P2RX2, DNAL4, CORT, TFF1) as those that mostly contributed to the 
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separation between normal weight and overweight children. The discriminatory power of the 
expression profile of the above-mentioned genes on TG levels within overweight children was 
further studied by considering each individual gene (Figure 4). For that, normal weight and 
overweight children were subdivided according to their gene expression levels (low vs high) by 
using the median value of each gene expression’s distribution of the whole sample as a cut-off 
point. Overweight children with high expression levels of most of the genes (ZNF418, NPPA, 
POLR1C, ADRB3, DNAL4, CORT and TFF1), exhibited higher TG levels than those with low 
expression levels (p<0.05, Student’s t-test), whereas no differences were found in normal 
weight children. In the case of P2RX2, the trend was similar, but differences were not 
statistically significant.  
Discussion 
To identify biomarkers that can be predictive of unhealthy metabolic alterations associated to 
overweight/obesity in children, we first performed a comparative analysis of the transcriptome 
profile in PBCs of normal weight and overweight children. Overall 1,077 known coding genes 
differently expressed between these two groups of children were detected, clearly separated by 
both PLS-DA and the heat map. Microarray data were confirmed by RT-qPCR performed for a 
selection of 10 genes.  
Pathway enrichment analysis revealed that the most significant enriched pathway was related to 
mitochondrial oxidative phosphorylation. Most of the genes involved in this pathway were 
down-regulated in overweight compared to normal weight children. A reduction in the 
expression levels of genes involved in the oxidative phosphorylation has also been described in 
the skeletal muscle (21, 22), visceral adipose tissue (23) and in PBMCs (24) from adult patients 
with type 2 diabetes. It has also been reported that the reduction in the set of genes involved in 
oxidative phosphorylation in PBMCs seems to be intrinsic to the diabetic state since altered 
expression was not changed by glycaemic control (24). Notably, overweight children involved 
in the present study were not diagnosed with type 2 diabetes, although they displayed higher 
insulin levels and HOMA index values compared to normal weight children with no alteration 
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in fasting glucose levels. In addition, we also observed a parallel reduction in key genes of the 
TCA cycle and of genes encoding for two subunits of the pyruvate dehydrogenase complex, 
which catalyses the conversion of pyruvate to acetyl-CoA and provides the primary link 
between glycolysis and the TCA cycle. Conversely, pyruvate carboxylase, which catalyses the 
carboxylation of pyruvate to oxaloacetate, was up-regulated in overweight children, suggesting 
that pyruvate may be driven to the conversion to oxaloacetate more than to acetyl-CoA. Overall, 
the expression level of key genes in PBCs pointed to a disturbed oxidative capacity in 
overweight children, which could reflect impairment in other internal tissues. This may be a 
hallmark of overweight/obesity, also indicative of a pre-diabetic state, regardless of an alteration 
in glucose levels. 
Moreover, also in reference to type 2 diabetes, differences in the expression levels of 
transcription factor 7-like 2 (TCF7L2) may be of potential interest. TCF7L2 is a key regulator 
of (pro)insulin synthesis and processing (25). TCF7L2 harbors common genetic variants 
(particularly the single-nucleotide polymorphism rs7903146) with the strongest and most 
widely replicated effect on type 2 diabetes risk already described (26, 27). The risk T-allele of 
rs7903146 has been associated with impaired glucose-stimulated insulin secretion and 
processing and increased insulin resistance (28), and carriers of the T-allele have been reported 
to display increased expression of TCF7L2 in human pancreatic islets (29). The frequency of 
the risk T-allele has been found to be higher not only in diabetic patients, but also in those who 
develop macro-vascular complications (30). Moreover, centenarians show the lowest frequency 
of T-allele and the highest frequency of C-allele, which emerges as a protective longevity 
variant (30).  
Notably, in the present study, TCF7L2 has been identified as one of the genes differently 
expressed between normal weight and overweight children, being up-regulated in overweight 
children. These results might suggest a higher presence of the risk T-allele in overweight 
individuals, although this has not been addressed here since it was not the objective of the study. 
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In any case, present findings show that greater TCF7L2 expression levels in PBCs, regardless of 
the polymorphism variant, may by indicative of higher risk of obesity and diabetes in children. 
PLS-DA is considered a powerful and simple tool for analysing microarray data that allows to 
predict the phenotype given the expression levels (31). Here, PLS-DA was successfully applied 
to select a more reduced number of gene transcripts to discriminate between overweight and 
normal weight subjects. The 10 genes, whose transcripts have been identified as most relevant 
to the discrimination between overweight and normal weight children in our PLS-DA model, 
were related to metabolism (ADRB3), nervous system (NEGR1), neuronal signalling (CORT 
and P2RX2), signalling (IL15RA), vascular homeostasis (NPPA), transcription/translation 
machinery (POLR1C and ZNF418), cytoskeleton (DNAL4) and TFF1. mRNA levels of all of 
them were up-regulated in PBCs of overweight compared to normal weight children. Moreover, 
using a new PLS-DA model, we defined a set of genes whose expression levels may 
discriminate between overweight individuals with high or low TG levels. It is worth noting that 
the latter set of genes includes 8 of the list of 10 genes above mentioned (ZNF418, NPPA, 
POLR1C, ADRB3, P2RX2, DNAL4, CORT and TFF1). Other genes with a relevant role in 
lipid metabolism (such as LIPE), or glucose homeostasis (such as GIPR) are also included. Both 
genes were also up-regulated in overweight children. 
Some genes identified as candidate biomarkers in both PLS-DA models seem to be especially 
remarkable in terms of biological plausibility regarding body weight and metabolic aspects. 
Particularly, ADRB3 is related to lipid metabolism. The ADRB3 gene encodes for the 
adrenergic receptor beta 3, which is mainly present in adipose tissue and involved in the 
regulation of lipolysis and thermogenesis. A single nucleotide polymorphism in the coding 
region of this gene has been associated with childhood obesity and other features of the 
metabolic syndrome (32).  
In addition, genome-wide association studies have identified sequence variants of loci near to 
NEGR1 and GIPR associated with BMI (33-35). GIPR encodes a G-protein coupled receptor 
©    2017 Macmillan Publishers Limited. All rights reserved.
14 
 
for gastric inhibitory polypeptide (GIP). GIP is well known for its insulin tropic action and its 
secretion is stimulated by both fat and glucose (36). In mice, knock-out or antagonism of GIPR 
protects from obesity and metabolic abnormalities, such us insulin resistance induced by the 
consumption of a high-fat diet (37, 38). In humans, GIP has been shown to increase adipose 
tissue expression and plasma concentration of MCP-1 and seems to promote a crosstalk between 
macrophages and adipocytes to induce an inflammatory response associated to high-density 
food intake and obesity (39). Regarding NEGR1, the protein encoded by this gene is a cell 
adhesion molecule expressed in different areas of CNS. Experimental data with NEGR1-
deficient mice showed that the loss of function of NEGR1 has negative consequences on body 
mass and produces a reduction in food intake, although the mechanisms involved are still 
unknown (40). In humans, the at-risk allele of the associated variant (rs2568958) has been 
related to increased expression (per allele copy) of NEGR1 in blood (34), pointing that up-
regulation of NEGR1 in human may be associated to increased BMI (40).  
CORT may also be of potential interest. This gene encodes for the cortistatin (CORT) 
neuropeptide, which shares high structural and functional similarities with somatostatin (SST). 
In addition to their roles in the CNS, both peptides also regulate endocrine secretion. CORT has 
been shown to bind with high affinity to the ghrelin receptor (GHSR) and play important actions 
on pancreatic function (41). In islets isolated from C57BL6 mice, CORT action has been 
reported to reduce the glucose-stimulated insulin secretion (42). Therefore, the presence of 
higher expression levels of this gene in PBCs from overweight children may also be in 
agreement with a greater predisposition to type 2 diabetes.  
Despite the care taken in selecting the study cohort to have a similar number of normal weight 
and overweight children within the range of age considered, the study has the limitation that the 
mean age of the overweight group is significantly higher than that of the normal weight group. 
Although it is not expected that the age difference is responsible for the differences found 
between groups, it does lead to limitations in the interpretation of the results that may be 
considered in further studies. Another fact to take into account is the use of the whole fraction of 
©    2017 Macmillan Publishers Limited. All rights reserved.
15 
 
blood cells, instead of PBMC sub-populations, because this provides methodological 
advantages. Therefore, differences in PBMC sub-populations could be masking some changes 
in gene expression that could be used as early biomarkers. Finally, the cross-sectional nature of 
the study may also be considered as a limitation, since it may not provide definite information 
on cause-and-effect relationships. The predictive value of the identified biomarkers needs 
further validation in follow-up studies.  
In summary, functional microarray analysis of PBCs from normal weight and overweight 
children has revealed early changes associated to overweight, indicative of a reduced capacity of 
metabolic handling through the TCA cycle and oxidative phosphorylation, which, if generalized 
to other tissues, may contribute to the energy imbalance and later metabolic disorders. 
Moreover, other genes related with glucose homeostasis and lipid metabolism revealed other 
putative mechanisms according to biological knowledge. With a PLS-DA model, a set of 
potential transcript-based biomarkers has been identified that, once validated in future studies, 
may be a useful approach for early identification of children with higher predisposition to 
obesity and its related metabolic alterations, particularly in terms of insulin resistance and 
hypertriglyceridemia. However, due to the cross-sectional nature of the analysis, the predictive 
value of the identified biomarkers should be considered with some reservations and requires 
verification. 
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Figure 1. Heat map representing individual expression data of genes differentially expressed in 
PBCs between normal and overweight children from the IDEFICS study. Rows represent the set 
of 1,077 differentially expressed genes, sorted by fold change. Columns represent log2-
transformed gene expression values for each gene in each individual.  
Figure 2. A) Partial least square discriminant analysis (PLS-DA) plots involving 1,077 genes 
differentially expressed between normal weight and overweight. B) PLS-DA plot including the 
genes with the highest loading score from the first PLS-DA (Supplemental Table 2). C) Plot 
with variable loading from PLS-DA showed in C with the 10 variables that contributed the most 
to variability of individual expression data. PLS-DA analysis was performed using the Excel 
add-in Multibase package (Numerical Dynamics, Japan). 
Figure 3. Partial least square discriminant analysis (PLS-DA) for discrimination of individuals 
with high and low levels of triglycerides (HighTG; LowTG) within normal weight and 
overweight children (NW; OW), including 1,077 genes differentially expressed between normal 
weight and overweight.  
Figure 4. Triglyceride levels in children with low and high expression levels of specific genes 
in blood cells. Genes selected were: ZNF418, NPPA, POLR1C, ADRB3, P2RX2, DNAL4, 
CORT or TFF1. Results are mean ± standard error of the mean. Statistics: W, effect of BMI; E, 
effect of expression levels (low vs high), WxE, interactive effect of BMI and expression levels 
(p<0.05 two-way ANOVA);*p<0.05 high vs low expression levels (Student's t-test); p<0.05 
overweight vs normal weight (Student's t-test). 
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Table 1. General characteristics, anthropometry and biochemical parameters in the population 
analysed in the study. BMI, body mass index. BMI z-score according to Cole et al (20), 
Subcutaneous fat represents the sum of four different skin folds (subscapular, biceps, triceps and 
suprailliac crest). Statistics: *,** differences between overweight and normal weight children 
(p<0.05 and p<0.01, respectively, by Student's t-test). 
 
 Normal weight 
(n=17; 9 ♂+ 8♀) 
Overweight 
(n=15; 7 ♂+ 8♀) 
Weight(kg) 19.7 ± 0.7 36.4 ± 1.2** 
BMI (kg/m2) 14.6 ± 0.3 22.5 ± 0.4** 
BMI z-score (kg/m2) -0.56 ± 0.21 2.71 ± 0.10** 
Age (years) 6.3 ± 0.3 7.1 ± 0.2* 
Subcutaneous fat (mm) 22.8 ± 2.3 66.2 ± 2.6** 
Waist/height Ratio  0.441 ± 0.008 0.563 ± 0.010** 
Insulin (µIU/mL) 3.96 ± 0.76 8.27 ± 0.89** 
Glucose (mg/dL) 83.4 ± 2.2 87.2 ± 1.7 
HOMA index 0.84 ± 0.17 1.76 ± 0.17 ** 
Triglycerides (mg/dL) 51.1 ±4.0 67. 9± 6.1* 
HDL cholesterol (mg/dL) 53.9 ± 4.4 49.5 ± 3.4 
LDL cholesterol (mg/dL) 87.6 ± 4.9 90.5 ± 7.9 
Total cholesterol (mg/dL) 151.7 ± 6.3 153.5 ± 8.6 
Total cholesterol/HDL cholesterol  3.0 ± 0.2 3.3 ± 0.2 
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Table 2. Top 10 ranked pathways from MetaCore pathway analysis. Pathways are ranked based 
upon p-value. 
 Pathway pValue FDR Ratio 
1 Oxidative phosphorylation 7.937E-09 5.413E-06 20/105 
2 
Development Role of HDAC and calcium/calmodulin-
dependent kinase (CaMK) in control of skeletal myogenesis 
9.963E-06 3.397E-03 11/54 
3 Cell cycle_Initiation of mitosis 4.890E-05 8.513E-03 7/25 
4 Signal transduction_AKT signaling 5.149E-05 8.513E-03 9/43 
5 Immune response_IL-4 signaling pathway 6.241E-05 8.513E-03 9/44 
6 Cell cycle_Chromosome condensation in prometaphase 1.527E-04 1.529E-02 6/21 
7 Regulation of degradation of deltaF508-CFTR in CF 1.570E-04 1.529E-02 8/39 
8 Cell cycle_Sister chromatid cohesion 2.027E-04 1.675E-02 6/22 
9 
Signal transduction_Activation of PKC via G-Protein coupled 
receptor 
2.418E-04 1.675E-02 9/52 
10 Immune response_IL-15 signaling via JAK-STAT cascade 2.648E-04 1.675E-02 6/23 
 
©    2017 Macmillan Publishers Limited. All rights reserved.
Figure 1



















































©    2017 Macmillan Publishers Limited. All rights reserved.
Figure 4
©    2017 Macmillan Publishers Limited. All rights reserved.
